cAMP-secretion coupling is impaired in diabetic GK/Par rat β-cells: a defect counteracted by GLP-1.

cAMP-raising agents with glucagon-like peptide-1 (GLP-1) as the first in class, exhibit multiple actions that are beneficial for the treatment of type 2 diabetic (T2D) patients, including improvement of glucose-induced insulin secretion (GIIS). To gain additional insight into the role of cAMP in the disturbed stimulus-secretion coupling within the diabetic β-cell, we examined more thoroughly the relationship between changes in islet cAMP concentration and insulin release in the GK/Par rat model of T2D. Basal cAMP content in GK/Par islets was significantly higher, whereas their basal insulin release was not significantly different from that of Wistar (W) islets. Even in the presence of IBMX or GLP-1, their insulin release did not significantly change despite further enhanced cAMP accumulation in both cases. The high basal cAMP level most likely reflects an increased cAMP generation in GK/Par compared with W islets since 1) forskolin dose-dependently induced an exaggerated cAMP accumulation; 2) adenylyl cyclase (AC)2, AC3, and G(s)α proteins were overexpressed; 3) IBMX-activated cAMP accumulation was less efficient and PDE-3B and PDE-1C mRNA were decreased. Moreover, the GK/Par insulin release apparatus appears less sensitive to cAMP, since GK/Par islets released less insulin at submaximal cAMP levels and required five times more cAMP to reach a maximal secretion rate no longer different from W. GLP-1 was able to reactivate GK/Par insulin secretion so that GIIS became indistinguishable from that of W. The exaggerated cAMP production is instrumental, since GLP-1-induced GIIS reactivation was lost in the presence the AC blocker 2',5'-dideoxyadenosine. This GLP-1 effect takes place in the absence of any improvement of the [Ca(2+)](i) response and correlates with activation of the cAMP-dependent PKA-dependent pathway.

[1]  G. Lacraz,et al.  Diabetic GK/Par rat beta-cells are spontaneously protected against H2O2-triggered apoptosis. A cAMP-dependent adaptive response. , 2010, American journal of physiology. Endocrinology and metabolism.

[2]  G. Lacraz,et al.  Islet structure and function in the GK rat. , 2010, Advances in experimental medicine and biology.

[3]  M. Prentki,et al.  Glucagon-Like Peptide-1 Induced Signaling and Insulin Secretion Do Not Drive Fuel and Energy Metabolism in Primary Rodent Pancreatic β-Cells , 2009, PloS one.

[4]  J. Henquin.  Regulation of insulin secretion: a matter of phase control and amplitude modulation , 2009, Diabetologia.

[5]  M. Dolz,et al.  The GK rat beta-cell: A prototype for the diseased human beta-cell in type 2 diabetes? , 2009, Molecular and Cellular Endocrinology.

[6]  L. Levin,et al.  Glucose and GLP-1 Stimulate cAMP Production via Distinct Adenylyl Cyclases in INS-1E Insulinoma Cells , 2008, The Journal of general physiology.

[7]  A. Tengholm,et al.  Oscillations of cyclic AMP in hormone-stimulated insulin-secreting β-cells , 2006, Nature.

[8]  M. Dolz,et al.  Restitution of defective glucose-stimulated insulin secretion in diabetic GK rat by acetylcholine uncovers paradoxical stimulatory effect of beta-cell muscarinic receptor activation on cAMP production. , 2005, Diabetes.

[9]  T. Shibasaki,et al.  PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. , 2005, Physiological reviews.

[10]  M. Lohse,et al.  Interplay of Ca2+ and cAMP Signaling in the Insulin-secreting MIN6 β-Cell Line*[boxs] , 2005, Journal of Biological Chemistry.

[11]  W. Malaisse,et al.  The role of cyclic AMP in insulin release , 1984, Experientia.

[12]  G. Sharp,et al.  The Adenylate cyclase-cyclic AMP system in islets of langerhans and its role in the control of insulin release , 1979, Diabetologia.

[13]  W. Malaisse,et al.  The stimulus-secretion coupling of glucose-induced insulin release , 1979, Diabetologia.

[14]  S. Durán-García,et al.  Effect of gestational diabetes on insulin receptors in human placenta , 1979, Diabetologia.

[15]  P. Insel,et al.  Forskolin as a Tool for Examining Adenylyl Cyclase Expression, Regulation, and G Protein Signaling , 2003, Cellular and Molecular Neurobiology.

[16]  S. Efendić,et al.  PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets , 2003, Regulatory Peptides.

[17]  E. Degerman,et al.  Important Role of Phosphodiesterase 3B for the Stimulatory Action of cAMP on Pancreatic β-Cell Exocytosis and Release of Insulin* , 2002, The Journal of Biological Chemistry.

[18]  G. Portela-Gomes,et al.  Overexpression of Gs Proteins and Adenylyl Cyclase in Normal and Diabetic Islets , 2002, Pancreas.

[19]  T. Shibasaki,et al.  Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion* , 2001, The Journal of Biological Chemistry.

[20]  S. Abdel-Halim,et al.  Glucose Enhances Adenylyl Cyclase Responses in Normal But Not Diabetic GK Rat Islets , 2001, Pancreas.

[21]  M. Bader,et al.  Phospholipase D in rat myometrium: occurrence of a membrane-bound ARF6 (ADP-ribosylation factor 6)-regulated activity controlled by betagamma subunits of heterotrimeric G-proteins. , 2000, The Biochemical journal.

[22]  Yasuhiro Sunaga,et al.  cAMP-GEFII is a direct target of cAMP in regulated exocytosis , 2000, Nature Cell Biology.

[23]  C. Gespach,et al.  Decreased ADP-Ribosylation of the Gαolf and Gαs Subunits by High Glucose in Pancreatic B-Cells , 2000 .

[24]  S. Efendić,et al.  Adenylyl cyclase isoform expression in non-diabetic and diabetic Goto-Kakizaki (GK) rat pancreas. Evidence for distinct overexpression of type-8 adenylyl cyclase in diabetic GK rat islets , 2000, Histochemistry and Cell Biology.

[25]  C. Gespach,et al.  Decreased ADP-ribosylation of the Galpha(olf) and Galpha(s) subunits by high glucose in pancreatic B-cells. , 2000, Biochemical and biophysical research communications.

[26]  T. Michaeli,et al.  The Calcium/Calmodulin-dependent Phosphodiesterase PDE1C Down-regulates Glucose-induced Insulin Secretion* , 1999, The Journal of Biological Chemistry.

[27]  W. Malaisse,et al.  Gαolf identification by RT-PCR in purified normal pancreatic B cells and in islets from rat models of non-insulin-dependent diabetes , 1999 .

[28]  W. Malaisse,et al.  Galphaolf identification by RT-PCR in purified normal pancreatic B cells and in islets from rat models of non-insulin-dependent diabetes. , 1999, Biochemical and biophysical research communications.

[29]  S. Efendić,et al.  Mutations in the promoter of adenylyl cyclase (AC)-III gene, overexpression of AC-III mRNA, and enhanced cAMP generation in islets from the spontaneously diabetic GK rat model of type 2 diabetes. , 1998, Diabetes.

[30]  J. Holst,et al.  Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic β-Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling , 1998, Diabetes.

[31]  B. Portha,et al.  Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies. , 1997, The Journal of endocrinology.

[32]  P. Rorsman,et al.  Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors , 1997, Pflügers Archiv.

[33]  J. Gromada,et al.  Protein Kinase A-Dependent Stimulation of Exocytosis in Mouse Pancreatic β-Cells by Glucose-Dependent Insulinotropic Polypeptide , 1997, Diabetes.

[34]  B. Portha,et al.  Glucagon-like peptide-1 ( 7 – 36 )-amide confers glucose sensitivity to previously glucose-incompetent â-cells in diabetic rats : in vivo and in vitro studies , 1997 .

[35]  H. Hidaka,et al.  Ca2+/calmodulin and cyclic 3,5' adenosine monophosphate control movement of secretory granules through protein phosphorylation/dephosphorylation in the pancreatic beta-cell. , 1996, Endocrinology.

[36]  B. Portha,et al.  Decreased glucose-induced cAMP and insulin release in islets of diabetic rats: reversal by IBMX, glucagon, GIP. , 1996, The American journal of physiology.

[37]  O. Larsson,et al.  Impaired Coupling of Glucose Signal to the Exocytotic Machinery in Diabetic GK Rats , 1996, Diabetes.

[38]  P. Rorsman,et al.  Glucagon-Like Peptide I Increases Cytoplasmic Calcium in Insulin-Secreting βTC3-Cells by Enhancement of Intracellular Calcium Mobilization , 1995, Diabetes.

[39]  P. Rorsman,et al.  Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization. , 1995, Diabetes.

[40]  D. Hanahan,et al.  Constitutively active stimulatory G-protein alpha s in beta-cells of transgenic mice causes counterregulation of the increased adenosine 3',5'-monophosphate and insulin secretion. , 1994, Endocrinology.

[41]  M. Nakata,et al.  Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity. , 1993, Endocrinology.

[42]  J. Habener,et al.  Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37) , 1993, Nature.

[43]  C. Wollheim,et al.  Guanine nucleotides induce Ca2+-independent insulin secretion from permeabilized RINm5F cells. , 1987, The Journal of biological chemistry.